Real-world study of 20,368 cataract operations: do intraoperative sub-conjunctival steroids reduce rate of cystoid macular oedema (CMO) following cataract surgery?

Session Details

Session Title: Cataract Surgery & Retinal Complications

Session Date/Time: Tuesday 25/09/2018 | 16:30-18:00

Paper Time: 16:30

Venue: Room A3, Podium 1

First Author: : M.Teo UK

Co Author(s): :    P. Ursell   R. Muniraju                 

Abstract Details

Purpose:

To assess if intra-operative subconjunctival (SC) steroids have an effect on rates of post-operative CMO in normal patients, and in diabetics with and without diabetic retinopathy.

Setting:

This was a retrospective, single-centre, non-randomised observational case series studying 20,368 cataract surgeries collected via the electronic patient record at Epsom and St Helier Hospitals, London, UK from Oct 2007 to November 2017.

Methods:

The rate of cystoid macular oedema (recorded within 3 months of cataract operation) and whether or not SC steroids were administered intra-operatively were analysed in patients with uncomplicated operations (no PC rupture, vitreous loss, choroidal haemorrhage, iris trauma). Patients were divided into 3 categories, (a) normal (non-diabetics), (b) diabetics without retinopathy or (c) with retinopathy.

Results:

There was no difference in incidence of raised IOP ( >21mmHg) between the groups who did and did not receive subconjunctival steriods (0.75% in both groups).

Conclusions:

In this large study, intra-operative subconjunctival steroids appear to reduce rate of CMO in all categories, particularly high risk diabetic patients with known diabetic retinopathy.

Financial Disclosure:

-